Correlation Between Bridge Biotherapeutics and Cytogen

Can any of the company-specific risk be diversified away by investing in both Bridge Biotherapeutics and Cytogen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bridge Biotherapeutics and Cytogen into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bridge Biotherapeutics and Cytogen, you can compare the effects of market volatilities on Bridge Biotherapeutics and Cytogen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bridge Biotherapeutics with a short position of Cytogen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bridge Biotherapeutics and Cytogen.

Diversification Opportunities for Bridge Biotherapeutics and Cytogen

0.46

Correlation Coefficient

Bridge Biotherapeutics  Cytogen

Very weak diversification

The 3 months correlation between Bridge and Cytogen is 0.46. Overlapping area represents the amount of risk that can be diversified away by holding Bridge Biotherapeutics and Cytogen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cytogen and Bridge Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bridge Biotherapeutics are associated (or correlated) with Cytogen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cytogen has no effect on the direction of Bridge Biotherapeutics i.e., Bridge Biotherapeutics and Cytogen go up and down completely randomly.

Pair Corralation between Bridge Biotherapeutics and Cytogen

Assuming the 90 days trading horizon Bridge Biotherapeutics is expected to generate 1.18 times more return on investment than Cytogen. However, Bridge Biotherapeutics is 1.18 times more volatile than Cytogen. It trades about 0.12 of its potential returns per unit of risk. Cytogen is currently generating about -0.1 per unit of risk. If you would invest  336,500  in Bridge Biotherapeutics on September 26, 2024 and sell it today you would earn a total of  68,500  from holding Bridge Biotherapeutics or generate 20.36% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	95.65%
Values	Daily Returns

Bridge Biotherapeutics  vs.  Cytogen

Bridge Biotherapeutics

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Bridge Biotherapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Bridge Biotherapeutics sustained solid returns over the last few months and may actually be approaching a breakup point.

Cytogen

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Cytogen has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Bridge Biotherapeutics and Cytogen

The main advantage of trading using opposite Bridge Biotherapeutics and Cytogen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bridge Biotherapeutics position performs unexpectedly, Cytogen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cytogen will offset losses from the drop in Cytogen's long position.

The idea behind Bridge Biotherapeutics and Cytogen pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.